Investors picked up blue chip stocks following an upbeat job creation report and an increase in November factory orders. The Dow rose 60 points to 13,104 while Nasdaq added a point to 2611.
On the upside
Sciele Pharma (Nasdaq: SCRX) received FDA approval to sell a new version of its high blood pressure drug treatment.
Seed company Monsanto (NYSE: MON) posted earnings that tripled citing strong Latin American results.
Investors continued to snap up shares of Akeena Solar (Nasdaq: AKNS) which traded at new highs.
On the downside
Shares of CVS Caremark (NYSE: CVS) lost ground after the drugstore chain operator updated its outlook toward the low end of analysts' expectations.
Bakery and cafe chain Panera Bread (Nasdaq: PNRA) posted higher revenues, but unfavorable weather conditions hurt same-store sales results.
In the broad market, advancing issues outpaced decliners by a margin of nearly 2 to 1 on the NYSE and by a slim margin on Nasdaq. The Russell 2000 which tracks small cap stocks added 2 points to 756.